Covered recipient · General Payments record
BROOKE A HUDSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,186.49
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $468.37 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $177.30 | 6 |
| Novo Nordisk AS | $95.96 | 1 |
| Acerta Pharma LLC | $41.34 | 3 |
| Grifols USA, LLC | $33.02 | 2 |
| ABBVIE INC. | $32.97 | 1 |
| Mylan Specialty L.P. | $32.51 | 2 |
| ANI Pharmaceuticals, Inc. | $21.00 | 1 |
| Organon LLC | $17.27 | 1 |
| Neurocrine BioSciences, Inc. | $17.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.97 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107366027 | CMS |
| ANI Pharmaceuticals, Inc. | $21.00 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091132695 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.64 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104438027 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.85 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105839903 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.85 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104446807 | CMS |
| Grifols USA, LLC | $17.72 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124716071 | CMS |
| Grifols USA, LLC | $15.30 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124716069 | CMS |
| Mylan Specialty L.P. | $13.85 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147309860 | CMS |
| Mylan Specialty L.P. | $18.66 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147374717 | CMS |
| Neurocrine Biosciences, Inc. | $17.00 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150994978 | CMS |
| Novo Nordisk Inc | $95.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100515149 | CMS |
| Organon Llc | $17.27 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136268269 | CMS |
| UCB, Inc. | $31.04 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255606 | CMS |
| UCB, Inc. | $29.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255610 | CMS |
| UCB, Inc. | $38.97 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255614 | CMS |
| UCB, Inc. | $26.57 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255619 | CMS |
| UCB, Inc. | $26.04 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255623 | CMS |
| UCB, Inc. | $24.99 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143255628 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.